Guangshi Tao

Changsha, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Transvaginal single-pathway composite reconstruction for pelvic organ prolapse combined with rectal prolapse: a case report.

Transvaginal single-pathway composite reconstruction for pelvic organ prolapse combined with rectal prolapse: a case report.

Journal: Frontiers in surgery
Published: May 06, 2026

Effectiveness of Self-cut vs Mesh-Kit Titanium-Coated Polypropylene Mesh for Transvaginal Treatment of Severe Pelvic Organ Prolapse: A Multicenter Randomized Noninferiority Clinical Trial.

Effectiveness of Self-cut vs Mesh-Kit Titanium-Coated Polypropylene Mesh for Transvaginal Treatment of Severe Pelvic Organ Prolapse: A Multicenter Randomized Noninferiority Clinical Trial.

Journal: JAMA network open
Published: September 16, 2022

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.

Journal: BMC cancer
Published: August 09, 2022

Clinical characteristics of 1,055 Chinese patients with Mayer-Rokitansky-Küster-Hauser syndrome: a nationwide multicentric study.

Clinical characteristics of 1,055 Chinese patients with Mayer-Rokitansky-Küster-Hauser syndrome: a nationwide multicentric study.

Journal: Fertility and sterility
Published: November 01, 2020

Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy.

Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy.

Journal: Cell discovery
Published: October 04, 2020

CRISPR-edited CART with GM-CSF knockout and auto secretion of IL6 and IL1 blockers in patients with hematologic malignancy.

CRISPR-edited CART with GM-CSF knockout and auto secretion of IL6 and IL1 blockers in patients with hematologic malignancy.

Journal: Cell discovery
Published: July 25, 2020

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer.

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer.

Journal: Journal of ovarian research
Published: June 30, 2020

Diagnosis and Management of Mixed Gestational Trophoblastic Neoplasia: A Study of 16 Cases and a Review of the Literature.

Diagnosis and Management of Mixed Gestational Trophoblastic Neoplasia: A Study of 16 Cases and a Review of the Literature.

Journal: Frontiers in oncology
Published: August 25, 2019

Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma.

Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma.

Journal: American journal of cancer research
Published: March 27, 2019

Self-cut titanium-coated polypropylene mesh versus pre-cut mesh-kit for transvaginal treatment of severe pelvic organ prolapse: study protocol for a multicenter non-inferiority trial.

Self-cut titanium-coated polypropylene mesh versus pre-cut mesh-kit for transvaginal treatment of severe pelvic organ prolapse: study protocol for a multicenter non-inferiority trial.

Journal: Trials
Published: January 24, 2019

Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm.

Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm.

Journal: PloS one
Published: June 05, 2015

A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.

A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.

Journal: Nature genetics
Published: April 09, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026